PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 90 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $85,841 | -25.5% | 32,639 | 0.0% | 0.01% | -16.7% |
| Q2 2023 | $115,216 | +16.9% | 32,639 | +2.4% | 0.01% | 0.0% |
| Q1 2023 | $98,522 | -18.3% | 31,884 | +11.9% | 0.01% | -33.3% |
| Q4 2022 | $120,538 | +79.9% | 28,496 | +1.0% | 0.02% | +100.0% |
| Q3 2022 | $67,000 | -16.2% | 28,205 | 0.0% | 0.01% | -10.0% |
| Q2 2022 | $80,000 | -2.4% | 28,205 | -1.3% | 0.01% | 0.0% |
| Q1 2022 | $82,000 | -79.9% | 28,571 | -10.7% | 0.01% | -81.8% |
| Q2 2019 | $407,000 | -62.1% | 32,000 | +76.5% | 0.06% | -51.3% |
| Q2 2018 | $1,073,000 | -21.7% | 18,132 | +15.6% | 0.11% | -38.6% |
| Q2 2017 | $1,371,000 | +185.6% | 15,685 | +21.6% | 0.18% | +109.1% |
| Q1 2017 | $480,000 | – | 12,900 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,536,156 | $21,405,000 | 2.24% |
| Palo Alto Investors LP | 1,396,163 | $11,784,000 | 0.99% |
| Camber Capital Management LP | 1,950,000 | $16,458,000 | 0.98% |
| TANG CAPITAL MANAGEMENT LLC | 800,000 | $6,752,000 | 0.95% |
| Capital Impact Advisors, LLC | 147,303 | $1,243,000 | 0.52% |
| Sofinnova Investments, Inc. | 638,026 | $5,385,000 | 0.50% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 963,212 | $8,130,000 | 0.26% |
| RICE HALL JAMES & ASSOCIATES, LLC | 466,482 | $3,937,000 | 0.22% |
| PDT Partners, LLC | 204,238 | $1,724,000 | 0.14% |
| Eversept Partners, LP | 58,251 | $491,638 | 0.12% |